- $194.24m
- -$14.48m
- $134.48m
U.S. RESEARCH ROUNDUP-Bloom Energy, Ford, Tesla
RxSight tumbles as company cuts 2025 sales forecast
Brief: Rxsight Q2 Revenue USD 33.6 Million Vs. IBES Estimate USD 39.8 Million
Rxsight Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Rxsight Q1 Revenue USD 37.9 Million Vs. IBES Estimate USD 38.1 Million
U.S. RESEARCH ROUNDUP- CNB Financial, Disney, Triumph Group
U.S. RESEARCH ROUNDUP-American Express, Rxsight, Vertiv Holdings
U.S. STOCKS ON THE MOVE-US drugmakers, regional banks, chip stocks
U.S. STOCKS ON THE MOVE-Apple, Aldeyra Therapeutics, AllianceBernstein
U.S. STOCKS ON THE MOVE-Apple, Alibaba, ExxonMobil
Rxsight falls after slashing annual revenue forecast
Brief: Rxsight Q1 Revenue USD 37.9 Million Vs. IBES Estimate USD 39.8 Million
U.S. STOCKS ON THE MOVE-Dutch Bros, Affirm, Mattel
U.S. STOCKS ON THE MOVE-FedEx, Generac, Steel Dynamics
U.S. STOCKS ON THE MOVE-Tesla, Pinterest, IBM
Jefferies starts coverage on Rxsight with 'buy' on growth potential
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Beacon Roofing, Liberty Energy
U.S. RESEARCH ROUNDUP-Intuit, Itron, Workday
Rxsight Inc reports results for the quarter ended December 31 - Earnings Summary